# Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer

> **NCT00094081** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 861 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** tirapazamine (SR259075)
- **DRUG:** cisplatin
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00094081
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 861 (ACTUAL)
- **Last updated:** 2010-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094081, "Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00094081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*